A detailed history of Bank Of Nova Scotia transactions in Amgen Inc stock. As of the latest transaction made, Bank Of Nova Scotia holds 93,704 shares of AMGN stock, worth $29.3 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
93,704
Previous 314,640 70.22%
Holding current value
$29.3 Million
Previous $90.6 Million 70.6%
% of portfolio
0.06%
Previous 0.18%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$268.87 - $324.56 $59.4 Million - $71.7 Million
-220,936 Reduced 70.22%
93,704 $26.6 Million
Q4 2023

Feb 12, 2024

BUY
$255.7 - $288.46 $66.5 Million - $75 Million
260,012 Added 475.97%
314,640 $90.6 Million
Q3 2023

Nov 14, 2023

BUY
$218.65 - $271.46 $1.23 Million - $1.52 Million
5,609 Added 11.44%
54,628 $14.7 Million
Q2 2023

Aug 03, 2023

BUY
$214.27 - $253.37 $385,471 - $455,812
1,799 Added 3.81%
49,019 $10.9 Million
Q1 2023

May 11, 2023

SELL
$225.79 - $275.2 $1.84 Million - $2.25 Million
-8,171 Reduced 14.75%
47,220 $11.4 Million
Q4 2022

Feb 09, 2023

BUY
$229.03 - $291.01 $432,179 - $549,135
1,887 Added 3.53%
55,391 $14.5 Million
Q3 2022

Nov 10, 2022

SELL
$224.46 - $253.15 $27,608 - $31,137
-123 Reduced 0.23%
53,504 $12.1 Million
Q2 2022

Aug 05, 2022

SELL
$230.71 - $256.74 $5.05 Million - $5.62 Million
-21,899 Reduced 29.0%
53,627 $13 Million
Q1 2022

May 09, 2022

SELL
$219.27 - $242.57 $107 Million - $118 Million
-488,051 Reduced 86.6%
75,526 $18.3 Million
Q4 2021

Feb 11, 2022

BUY
$198.88 - $227.6 $91.2 Million - $104 Million
458,714 Added 437.44%
563,577 $127 Million
Q3 2021

Nov 12, 2021

BUY
$212.27 - $248.7 $2.01 Million - $2.35 Million
9,457 Added 9.91%
104,863 $22.3 Million
Q2 2021

Aug 12, 2021

BUY
$233.58 - $259.14 $22.3 Million - $24.7 Million
95,406 New
95,406 $23.3 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $167B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Bank Of Nova Scotia Portfolio

Follow Bank Of Nova Scotia and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Nova Scotia with notifications on news.